“PO-57 | Early Treatment With Atogepant Improves Sleep Quality Without Sleep-Related Adverse Events: A Prospective Observational Study: Alberto Boccalini,1 Luigi Francesco Iannone,1,2* Flavia Lo Castro,1 Daria Brovia,1 Marina Romozzi,3,4 Fabrizio Vernieri,5,6 Claudia Altamura,5,6 Simona Guerzoni1 | 1Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico Di Modena, Modena, Italy; 2Department of Biomedical, Metabolic, and Neural Science, University of Modena and Reggio Emilia, Modena, Italy; 3Dipartimento Universitario Di Neuroscienze, Università Cattolica Del Sacro Cuore, Rome, Italy; 4Neurologia, Dipartimento Di Neuroscienze, Organi Di Senso E Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; 5Headache Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy; 6Università Campus Bio-Medico Di Roma, Italy”. 2025. Confinia Cephalalgica 35 (S1). https://doi.org/10.4081/cc.2025.15880.